fda approval of tirzepatide for weight loss What Is Used for? Approved and Potential Uses Mounjaro vs. Zepbound: The Same

Rotate sites to avoid lipodystrophy

Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system

#WeightLossSupport...

From the ADA meeting yesterday, presentations and publications about survodutide bring a focus that goes beyond a stale weight loss focus.

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a randomized trial showed.Among 407 adults, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score from baseline to week 68 was -41.7 points in the semaglutide group and -27.5 points in the placebo group (P